B-Type natriuretic peptide levels and continuous-flow left ventricular assist devices

ASAIO Journal

Volumn 56, Issue 6, 2010, Pages 527-531

  Sareyyupoglu, Basar ^a   Boilson, Barry A ^a   Durham, Lucian A ^a   McGregor, Christopher G A ^a   Daly, Richard C ^a   Redfield, Margaret M ^a   Edwards, Brooks S ^a   Frantz, Robert P ^a   Pereira, Naveen L ^a   Park, Soon J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B-TYPE NATRIURETIC PEPTIDE; CONTINUOUS-FLOW; INVERSE CORRELATION; LEFT VENTRICULAR ASSIST DEVICES; MEAN AGES; PUMP FAILURE; PUMP SPEED;

HYDRODYNAMICS; PUMPS;

PEPTIDES;

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD; EVALUATION; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTHESIS FAILURE;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PROSTHESIS FAILURE;

EID: 78349280749     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181f127a7     Document Type: Article

References (13)

1. Mäntymaa P, Vuolteenaho O, Marttila M, Ruskoaho H: Atrial stretch induces rapid increase in brain natriuretic peptide butnot in atrial natriuretic peptide gene expression in vitro. Endocrinology 133: 1470-1473, 1993.
2. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N EnglJ Med 339: 321-328, 1998.
3. Yasue H, Yoshimura M, Sumida H, et al: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203, 1994.
4. Sodian R, Loebe M, Schmitt C, et al: Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 38: 1942-1949, 2001.
5. Xydas S, Rosen RS, Ng C, et al: Mechanical unloading leads toechocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 25: 7-15, 2006.
6. Loebe M, Muller J, Hetzer R: Ventricular assistance for recovery ofcardiac failure. Curr Opin Cardiol 14: 234-248, 1999.
7. Khan T, Delgado RM, Radovancevic B, et al: Dobutamine stressechocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): Hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 22: 137-146, 2003.
8. Potapov EV, Hennig F, Wagner FD, et al: Natriuretic peptides and E-selection as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg 27: 899-905, 2005.
9. Troughton RW, Prior DL, Pereira JJ, et al: Plasma B-type natriureticpeptide levels in systolic heart failure: Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43: 416-422, 2004.
10. Madigan JD, Barbone A, Choudhri AF, et al: Time course ofreverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121: 902-908, 2001.
11. Strunk A, Bhalla V, Clopton P, et al: Impact of the history ofcongestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: Results from the Breathing Not Properly Multinational Study. Am J Med 119: 69.e1-69.e11, 2006.
12. Brenden CK, Hollander JE, Guss D, et al: Gray zone BNP levels inheart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. Am Heart J 151: 1006-1011, 2006.
13. Anand IS, Fisher LD, Chiang YT, et al: Changes in brain natriureticpeptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107: 1278-1283, 2003.